Spychalski, Griffin B.
Lin, Andrew A.
Yang, Stephanie J.
Shen, Hanfei
Rosario, Jean
Tien, Kyle
French, Kate
Ghali, Miriyam
Yee, Stephanie
Yin, Melinda
Feldman, Michael D.
Conant, Emily F.
Weinstein, Susan P.
Carpenter, Erica L.
Issadore, David
Nayak, Anupma
Funding for this research was provided by:
Penn Center for Precision Medicine, University of Pennsylvania (Accelerator Fund, Accelerator Fund, Accelerator Fund, Accelerator Fund, Accelerator Fund, Accelerator Fund)
National Cancer Institute (R33CA278551, R33CA278551)
National Institute of Allergy and Infectious Diseases (5-R33-AI-147406-03)
Article History
Received: 28 January 2025
Accepted: 19 April 2025
First Online: 22 May 2025
Declarations
:
: All participants included in this study signed informed consent at the Hospital of the University of Pennsylvania (Philadelphia, PA) under IRB Protocol #833588.
: Not applicable.
: DI holds ownership interest, including patents, in Chip Diagnostics. The other authors declare no competing interests.